These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21788626)

  • 1. Cross-sectional and longitudinal changes of glucose effectiveness in relation to glucose tolerance: the insulin resistance atherosclerosis study.
    Lorenzo C; Wagenknecht LE; Karter AJ; Hanley AJ; Rewers MJ; Haffner SM
    Diabetes Care; 2011 Sep; 34(9):1959-64. PubMed ID: 21788626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study.
    Festa A; Williams K; D'Agostino R; Wagenknecht LE; Haffner SM
    Diabetes; 2006 Apr; 55(4):1114-20. PubMed ID: 16567536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects.
    Matsumoto K; Miyake S; Yano M; Ueki Y; Yamaguchi Y; Akazawa S; Tominaga Y
    Diabetes Care; 1997 Oct; 20(10):1562-8. PubMed ID: 9314636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT.
    Stefan N; Stumvoll M; Bogardus C; Tataranni PA
    Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1156-61. PubMed ID: 12582008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarker models as surrogates for the disposition index in the Insulin Resistance Atherosclerosis Study.
    Watkins SM; Rowe MW; Kolberg JA; Wagenknecht LE; Bergman RN
    Diabet Med; 2012 Nov; 29(11):1399-406. PubMed ID: 22413950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose.
    Festa A; D'Agostino R; Hanley AJ; Karter AJ; Saad MF; Haffner SM
    Diabetes; 2004 Jun; 53(6):1549-55. PubMed ID: 15161760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of glucose effectiveness from short IVGTT in individuals with different degrees of glucose tolerance.
    Morettini M; Di Nardo F; Burattini L; Fioretti S; Göbl C; Kautzky-Willer A; Pacini G; Tura A
    Acta Diabetol; 2018 Oct; 55(10):1011-1018. PubMed ID: 29931422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.
    Hanefeld M; Koehler C; Fuecker K; Henkel E; Schaper F; Temelkova-Kurktschiev T;
    Diabetes Care; 2003 Mar; 26(3):868-74. PubMed ID: 12610051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study.
    Faerch K; Vaag A; Holst JJ; Hansen T; Jørgensen T; Borch-Johnsen K
    Diabetes Care; 2009 Mar; 32(3):439-44. PubMed ID: 19056613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
    Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
    Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin sensitivity and secretion in Arab Americans with glucose intolerance.
    Salinitri FD; Pinelli NR; Martin ET; Jaber LA
    Diabetes Technol Ther; 2013 Dec; 15(12):1019-24. PubMed ID: 23919587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-Hour Postload Hyperglycemia Is a Stronger Predictor of Type 2 Diabetes Than Impaired Fasting Glucose.
    Fiorentino TV; Marini MA; Andreozzi F; Arturi F; Succurro E; Perticone M; Sciacqua A; Hribal ML; Perticone F; Sesti G
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3744-51. PubMed ID: 26274345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
    Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
    Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is bisphenol A exposure associated with the development of glucose intolerance and increased insulin resistance in Thais?
    Chailurkit LO; Tengpraettanakorn P; Chanprasertyotin S; Ongphiphadhanakul B
    Nutr Health; 2017 Sep; 23(3):185-191. PubMed ID: 28516806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sclerostin and Insulin Resistance in Prediabetes: Evidence of a Cross Talk Between Bone and Glucose Metabolism.
    Daniele G; Winnier D; Mari A; Bruder J; Fourcaudot M; Pengou Z; Tripathy D; Jenkinson C; Folli F
    Diabetes Care; 2015 Aug; 38(8):1509-17. PubMed ID: 26084344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.
    Ou HY; Yang YC; Wu HT; Wu JS; Lu FH; Chang CJ
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4717-23. PubMed ID: 23066121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or post oral glucose-load state.
    Avignon A; Boegner C; Mariano-Goulart D; Colette C; Monnier L
    Int J Obes Relat Metab Disord; 1999 May; 23(5):512-7. PubMed ID: 10375055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel biomarkers to monitor β-cell function and enable early detection of type 2 diabetes risk.
    Belongie KJ; Ferrannini E; Johnson K; Andrade-Gordon P; Hansen MK; Petrie JR
    PLoS One; 2017; 12(8):e0182932. PubMed ID: 28846711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin and C-peptide levels, pancreatic beta cell function, and insulin resistance across glucose tolerance status in Thais.
    Chailurkit LO; Jongjaroenprasert W; Chanprasertyothin S; Ongphiphadhanakul B
    J Clin Lab Anal; 2007; 21(2):85-90. PubMed ID: 17385686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.